Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection
Abstract Acinetobacter baumannii is a serious health threat with a high mortality rate. We have already reported prophylactic effects of IgYs raised against OmpA and Omp34 as well as against inactivated whole-cell (IWC) of A. baumannii in a murine pneumonia model. However, the infection was exacerba...
Guardado en:
Autores principales: | Abolfazl Jahangiri, Parviz Owlia, Iraj Rasooli, Jafar Salimian, Ehsan Derakhshanifar, Zahra Aghajani, Sajad Abdollahi, Saeed Khalili, Daryush Talei, Elham Darzi Eslam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/003868d4bba647bc94e9931e3ffa91af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potentials and limitations of microorganisms as renal failure biotherapeutics
por: Poonam Jain, et al.
Publicado: (2009) -
Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain
por: Derrick Johnson, et al.
Publicado: (2021) -
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
por: Prakash S, et al.
Publicado: (2011) -
A structure-based engineering approach to abrogate pre-existing antibody binding to biotherapeutics.
por: Joanne Lin, et al.
Publicado: (2021) -
The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
por: Delphine L. Lauté-Caly, et al.
Publicado: (2019)